Keywords: ec, approves, gsk, otc, orlistat, product, alli
EC approves GSK's OTC orlistat product alli
Article | 26 January 2009
The European Commission has approved UK drug major GlaxoSmithKline's non-prescription drug alli (orlistat 60mg), the first switch of a centrally-authorized ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
